Copyright Reports & Markets. All rights reserved.

Global Paresthesia Treatment Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Paresthesia Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Acute Paresthesia
      • 1.4.3 Chronic Paresthesia
    • 1.5 Market by Application
      • 1.5.1 Global Paresthesia Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinics
      • 1.5.4 Diagnosis Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Paresthesia Treatment Market Size
    • 2.2 Paresthesia Treatment Growth Trends by Regions
      • 2.2.1 Paresthesia Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Paresthesia Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Paresthesia Treatment Market Size by Manufacturers
      • 3.1.1 Global Paresthesia Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Paresthesia Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Paresthesia Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Paresthesia Treatment Key Players Head office and Area Served
    • 3.3 Key Players Paresthesia Treatment Product/Solution/Service
    • 3.4 Date of Enter into Paresthesia Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Paresthesia Treatment Market Size by Type (2014-2019)
    • 4.2 Global Paresthesia Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Paresthesia Treatment Market Size (2014-2019)
    • 5.2 Paresthesia Treatment Key Players in United States
    • 5.3 United States Paresthesia Treatment Market Size by Type
    • 5.4 United States Paresthesia Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Paresthesia Treatment Market Size (2014-2019)
    • 6.2 Paresthesia Treatment Key Players in Europe
    • 6.3 Europe Paresthesia Treatment Market Size by Type
    • 6.4 Europe Paresthesia Treatment Market Size by Application

    7 China

    • 7.1 China Paresthesia Treatment Market Size (2014-2019)
    • 7.2 Paresthesia Treatment Key Players in China
    • 7.3 China Paresthesia Treatment Market Size by Type
    • 7.4 China Paresthesia Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Paresthesia Treatment Market Size (2014-2019)
    • 8.2 Paresthesia Treatment Key Players in Japan
    • 8.3 Japan Paresthesia Treatment Market Size by Type
    • 8.4 Japan Paresthesia Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Paresthesia Treatment Market Size (2014-2019)
    • 9.2 Paresthesia Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Paresthesia Treatment Market Size by Type
    • 9.4 Southeast Asia Paresthesia Treatment Market Size by Application

    10 India

    • 10.1 India Paresthesia Treatment Market Size (2014-2019)
    • 10.2 Paresthesia Treatment Key Players in India
    • 10.3 India Paresthesia Treatment Market Size by Type
    • 10.4 India Paresthesia Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Paresthesia Treatment Market Size (2014-2019)
    • 11.2 Paresthesia Treatment Key Players in Central & South America
    • 11.3 Central & South America Paresthesia Treatment Market Size by Type
    • 11.4 Central & South America Paresthesia Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Medtronic
      • 12.1.1 Medtronic Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Paresthesia Treatment Introduction
      • 12.1.4 Medtronic Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.1.5 Medtronic Recent Development
    • 12.2 Omron Healthcare
      • 12.2.1 Omron Healthcare Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Paresthesia Treatment Introduction
      • 12.2.4 Omron Healthcare Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.2.5 Omron Healthcare Recent Development
    • 12.3 Boston Scientific
      • 12.3.1 Boston Scientific Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Paresthesia Treatment Introduction
      • 12.3.4 Boston Scientific Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.3.5 Boston Scientific Recent Development
    • 12.4 Stimwave
      • 12.4.1 Stimwave Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Paresthesia Treatment Introduction
      • 12.4.4 Stimwave Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.4.5 Stimwave Recent Development
    • 12.5 Nevro
      • 12.5.1 Nevro Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Paresthesia Treatment Introduction
      • 12.5.4 Nevro Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.5.5 Nevro Recent Development
    • 12.6 Cyberonics
      • 12.6.1 Cyberonics Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Paresthesia Treatment Introduction
      • 12.6.4 Cyberonics Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.6.5 Cyberonics Recent Development
    • 12.7 EnteroMedics
      • 12.7.1 EnteroMedics Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Paresthesia Treatment Introduction
      • 12.7.4 EnteroMedics Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.7.5 EnteroMedics Recent Development
    • 12.8 GlaxoSmithKline
      • 12.8.1 GlaxoSmithKline Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Paresthesia Treatment Introduction
      • 12.8.4 GlaxoSmithKline Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.8.5 GlaxoSmithKline Recent Development
    • 12.9 Bio-Medical Research
      • 12.9.1 Bio-Medical Research Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Paresthesia Treatment Introduction
      • 12.9.4 Bio-Medical Research Revenue in Paresthesia Treatment Business (2014-2019)
      • 12.9.5 Bio-Medical Research Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Paresthesia is an abnormal sensation such as tingling, tickling, pricking, numbness or burning of a person's skin with no apparent physical cause. The manifestation of a paresthesia may be transient or chronic, and may have any of dozens of possible underlying causes. The most familiar kind of paresthesia is the sensation known as "pins and needles" or of a limb "falling asleep". A less well-known and uncommon but important paresthesia is formication, the sensation of bugs crawling underneath the skin.
      Medications offered can include the immunosuppressant prednisone, intravenous gamma globulin (IVIG), anticonvulsants such as gabapentin or Gabitril and antiviral medication, depending on the underlying cause. In addition to treatment of the underlying disorder, palliative care can include the use of topical numbing creams, such as lidocaine or prilocaine.
      In 2018, the global Paresthesia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Paresthesia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Paresthesia Treatment development in United States, Europe and China.

      The key players covered in this study
      Medtronic
      Omron Healthcare
      Boston Scientific
      Stimwave
      Nevro
      Cyberonics
      EnteroMedics
      GlaxoSmithKline
      Bio-Medical Research

      Market segment by Type, the product can be split into
      Acute Paresthesia
      Chronic Paresthesia

      Market segment by Application, split into
      Hospital
      Clinics
      Diagnosis Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Paresthesia Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Paresthesia Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Paresthesia Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now